Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Amaducci, L. A.
Right arrow Articles by Schoenberg, B. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Amaducci, L. A.
Right arrow Articles by Schoenberg, B. S.
NEUROLOGY 1986;36:922
© 1986 American Academy of Neurology

Risk factors for clinically diagnosed Alzheimer's disease

A case-control study of an Italian population

Luigi A. Amaducci, MD, Laura Fratiglioni, MD, Walter A. Rocca, MD, MPH, Cesare Fieschi, MD, Paolo Livrea, MD, Daniela Pedone, MD, Laura Bracco, MD, Andrea Lippi, MD, Carlo Gandolfo, MD, Giovanni Bino, MD, Massimiliano Prencipe, MD, Meri L. Bonatti, MD, Floriano Girotti, MD, Francesco Carella, MD, Bruno Tavolato, MD, Salvatore Ferla, MD, Gian L. Lenzi, MD, Antonio Carolei, MD, Anna Gambi, PhD, Francesco Grigoletto, PhD and Bruce S. Schoenberg, MD, DrPH

We conducted a case-control study of 116 patients with the clinical diagnosis of Alzheimer's disease (AD) in seven Italian centers. One hundred sixteen hospital controls and 97 population controls were matched by age, sex, and region of residence to the cases. A structured questionnaire was administered to the next-of-kin of cases and controls by trained interviewers to identify possible risk factors. Genetic, viral, toxic, immunologic, medical, surgical, and personality factors were investigated. Dementia among first- or second-degree relatives and advanced age of the mother at subject's birth (age over 40) were associated with AD. Head trauma was more frequent in cases than in either hospital or population controls, but the differences were not significant. Our data did not confirm the previously reported association with antecedent thyroid disease or family history of Down's syndrome.

Address correspondence and reprint requests to Dr. Rocca, Neuroepidemiology Branch, NINCDS, NIH, Room 804, Federal Building, 7550 Wisconsin Avenue, Bethesda, MD 20892.

For the Study Group Participants, see Appendix.

Supported in part by the Italian National Research Council (CNR)—Grant no. 840221156, and carried out under the auspices of the Science and Technology Bilateral Agreement between Italy and the United States.

Accepted for publication November 21, 1985.




This article has been cited by other articles:


Home page
Am J EpidemiolHome page
D. B. Petitti, V. C. Crooks, V. Chiu, J. G. Buckwalter, and H. C. Chui
Incidence of Dementia in Long-term Hormone Users
Am. J. Epidemiol., March 15, 2008; 167(6): 692 - 700.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
C. Reitz, T. den Heijer, C. van Duijn, A. Hofman, and M.M.B. Breteler
Relation between smoking and risk of dementia and Alzheimer disease: The Rotterdam Study
Neurology, September 4, 2007; 69(10): 998 - 1005.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
E. Planel, K. E. G. Richter, C. E. Nolan, J. E. Finley, L. Liu, Y. Wen, P. Krishnamurthy, M. Herman, L. Wang, J. B. Schachter, et al.
Anesthesia Leads to Tau Hyperphosphorylation through Inhibition of Phosphatase Activity by Hypothermia
J. Neurosci., March 21, 2007; 27(12): 3090 - 3097.
[Abstract] [Full Text] [PDF]


Home page
Journals of Gerontology Series A: Biological Sciences and Medical SciencesHome page
L. W. Baum
Sex, Hormones, and Alzheimer's Disease
J. Gerontol. A Biol. Sci. Med. Sci., June 1, 2005; 60(6): 736 - 743.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
G. Levy, E. D. Louis, H. Mejia-Santana, L. Cote, H. Andrews, J. Harris, C. Waters, B. Ford, S. Frucht, S. Fahn, et al.
Lack of Familial Aggregation of Parkinson Disease and Alzheimer Disease
Arch Neurol, July 1, 2004; 61(7): 1033 - 1039.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
S Fleminger, D L Oliver, S Lovestone, S Rabe-Hesketh, and A Giora
Head injury as a risk factor for Alzheimer's disease: the evidence 10 years on; a partial replication
J. Neurol. Neurosurg. Psychiatry, July 1, 2003; 74(7): 857 - 862.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
B. B. Sherwin
Estrogen and Cognitive Functioning in Women
Endocr. Rev., April 1, 2003; 24(2): 133 - 151.
[Abstract] [Full Text] [PDF]


Home page
Epidemiol RevHome page
B. A. in 't Veld, L. J. Launer, M. M. B. Breteler, A. Hofman, and B. H. Ch. Stricker
Pharmacologic Agents Associated with a Preventive Effect on Alzheimer's Disease: A Review of the Epidemiologic Evidence
Epidemiol. Rev., December 1, 2002; 24(2): 248 - 268.
[Full Text] [PDF]


Home page
NeurologyHome page
T. Truelsen, D. Thudium, and M. Gronbaek
Amount and type of alcohol and risk of dementia: The Copenhagen City Heart Study
Neurology, November 12, 2002; 59(9): 1313 - 1319.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
P. P. Zandi, M. C. Carlson, B. L. Plassman, K. A. Welsh-Bohmer, L. S. Mayer, D. C. Steffens, J. C. S. Breitner, and for the Cache County Memory Study Investigators
Hormone Replacement Therapy and Incidence of Alzheimer Disease in Older Women: The Cache County Study
JAMA, November 6, 2002; 288(17): 2123 - 2129.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
H. M. Fillit
The Role of Hormone Replacement Therapy in the Prevention of Alzheimer Disease
Arch Intern Med, September 23, 2002; 162(17): 1934 - 1942.
[Abstract] [Full Text] [PDF]


Home page
Journals of Gerontology Series A: Biological Sciences and Medical SciencesHome page
B. R. Ott, D. Belazi, and K. L. Lapane
Cognitive Decline Among Female Estrogen Users in Nursing Homes
J. Gerontol. A Biol. Sci. Med. Sci., September 1, 2002; 57(9): M594 - 598.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
Y.-H. Suh and F. Checler
Amyloid Precursor Protein, Presenilins, and alpha -Synuclein: Molecular Pathogenesis and Pharmacological Applications in Alzheimer's Disease
Pharmacol. Rev., September 1, 2002; 54(3): 469 - 525.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
H. D. Nelson, L. L. Humphrey, P. Nygren, S. M. Teutsch, and J. D. Allan
Postmenopausal Hormone Replacement Therapy: Scientific Review
JAMA, August 21, 2002; 288(7): 872 - 881.
[Abstract] [Full Text] [PDF]


Home page
Journals of Gerontology Series A: Biological Sciences and Medical SciencesHome page
D. B. Petitti, J. G. Buckwalter, V. C. Crooks, and V. Chiu
Prevalence of Dementia in Users of Hormone Replacement Therapy as Defined by Prescription Data
J. Gerontol. A Biol. Sci. Med. Sci., August 1, 2002; 57(8): M532 - 538.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
Z. D. Mulla, M. G. Bruce, N. E. Rosenstein, and K. A. Shutt
Meningococcal Disease in College Students
JAMA, December 5, 2001; 286(21): 2668 - 2668.
[Full Text] [PDF]


Home page
NEJMHome page
B. A. in 't Veld, A. Ruitenberg, A. Hofman, L. J. Launer, C. M. van Duijn, T. Stijnen, M. M.B. Breteler, and B. H.C. Stricker
Nonsteroidal Antiinflammatory Drugs and the Risk of Alzheimer's Disease
N. Engl. J. Med., November 22, 2001; 345(21): 1515 - 1521.
[Abstract] [Full Text] [PDF]


Home page
Int J EpidemiolHome page
S. L Tyas, J. Manfreda, L. A Strain, and P. R Montgomery
Risk factors for Alzheimer's disease: a population-based, longitudinal study in Manitoba, Canada
Int. J. Epidemiol., June 1, 2001; 30(3): 590 - 597.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
E. S. LeBlanc, J. Janowsky, B. K. S. Chan, and H. D. Nelson
Hormone Replacement Therapy and Cognition: Systematic Review and Meta-analysis
JAMA, March 21, 2001; 285(11): 1489 - 1499.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
M. M. Rice, A. B. Graves, S. M. McCurry, L. E. Gibbons, J. D. Bowen, W. C. McCormick, and E. B. Larson
Postmenopausal Estrogen and Estrogen-Progestin Use and 2-Year Rate of Cognitive Change in a Cohort of Older Japanese American Women: The Kame Project
Arch Intern Med, June 12, 2000; 160(11): 1641 - 1649.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
J A Cervilla, M. Prince, and A. Mann
Smoking, drinking, and incident cognitive impairment: a cohort community based study included in the Gospel Oak project
J. Neurol. Neurosurg. Psychiatry, May 1, 2000; 68(5): 622 - 626.
[Abstract] [Full Text]


Home page
CMAJHome page
D. G. Munoz and H. Feldman
Causes of Alzheimer's disease
Can. Med. Assoc. J., January 1, 2000; 162(1): 65 - 72.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
K. M. Mehta, A. Ott, S. Kalmijn, A. J. C. Slooter, C. M. van Duijn, A. Hofman, and M. M. B. Breteler
Head trauma and risk of dementia and Alzheimer's disease: The Rotterdam Study
Neurology, December 1, 1999; 53(9): 1959 - 1959.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
K. Marder, M.-X. Tang, B. Alfaro, H. Mejia, L. Cote, E. Louis, Y. Stern, and R. Mayeux
Risk of Alzheimer's disease in relatives of Parkinson's disease patients with and without dementia
Neurology, March 1, 1999; 52(4): 719 - 719.
[Abstract] [Full Text]


Home page
NeurologyHome page
S. C. Waring, W. A. Rocca, R. C. Petersen, P. C. O'Brien, E. G. Tangalos, and E. Kokmen
Postmenopausal estrogen replacement therapy and risk of AD: A population-based study
Neurology, March 1, 1999; 52(5): 965 - 965.
[Abstract] [Full Text]


Home page
Arch NeurolHome page
D. G. Munoz
Is Exposure to Aluminum a Risk Factor for the Development of Alzheimer Disease?--No
Arch Neurol, May 1, 1998; 55(5): 737 - 739.
[Full Text] [PDF]


Home page
JAMAHome page
K. Yaffe, G. Sawaya, I. Lieberburg, and D. Grady
Estrogen Therapy in Postmenopausal Women: Effects on Cognitive Function and Dementia
JAMA, March 4, 1998; 279(9): 688 - 695.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
D. A. Evans, L. E. Hebert, L. A. Beckett, P. A. Scherr, M. S. Albert, M. J. Chown, D. M. Pilgrim, and J. O. Taylor
Education and Other Measures of Socioeconomic Status and Risk of Incident Alzheimer Disease in a Defined Population of Older Persons
Arch Neurol, November 1, 1997; 54(11): 1399 - 1405.
[Abstract] [PDF]


Home page
Arch NeurolHome page
G. D. Forno, D. X. Rasmusson, J. Brandt, K. A. Carson, R. Brookmeyer, J. Troncoso, and C. H. Kawas
Apolipoprotein E Genotype and Rate of Decline in Probable Alzheimer's Disease
Arch Neurol, April 1, 1996; 53(4): 345 - 350.
[Abstract] [PDF]


Home page
Arch NeurolHome page
L. Bracco, R. Gallato, F. Grigoletto, A. Lippi, V. Lepore, G. Bino, M. P. Lazzaro, F. Carella, T. Piccolo, C. Pozzilli, et al.
Factors Affecting Course and Survival in Alzheimer's Disease: A 9-Year Longitudinal Study
Arch Neurol, December 1, 1994; 51(12): 1213 - 1219.
[Abstract] [PDF]


Home page
Arch NeurolHome page
V. W. Henderson, A. Paganini-Hill, C. K. Emanuel, M. E. Dunn, and J. G. Buckwalter
Estrogen Replacement Therapy in Older Women: Comparisons Between Alzheimer's Disease Cases and Nondemented Control Subjects
Arch Neurol, September 1, 1994; 51(9): 896 - 900.
[Abstract] [PDF]


Home page
Arch Gen PsychiatryHome page
J. M. Silverman, G. Li, M. L. Zaccario, C. J. Smith, J. Schmeidler, R. C. Mohs, and K. L. Davis
Patterns of Risk in First-Degree Relatives of Patients With Alzheimer's Disease
Arch Gen Psychiatry, July 1, 1994; 51(7): 577 - 586.
[Abstract] [PDF]


Home page
ANN INTERN MEDHome page
J. C. S. Breitner
Clinical Genetics and Genetic Counseling in Alzheimer Disease
Ann Intern Med, October 15, 1991; 115(8): 601 - 606.
[Abstract] [PDF]


Home page
Arch NeurolHome page
L. A. Farrer, L. A. Cupples, L. Connor, P. A. Wolf, and J. H. Growdon
Association of Decreased Paternal Age and Late-Onset Alzheimer's Disease: An Example of Genetic Imprinting?
Arch Neurol, June 1, 1991; 48(6): 599 - 604.
[Abstract] [PDF]


Home page
Arch NeurolHome page
R. Mayeux, M. Sano, J. Chen, T. Tatemichi, and Y. Stern
Risk of Dementia in First-Degree Relatives of Patients With Alzheimer's Disease and Related Disorders
Arch Neurol, March 1, 1991; 48(3): 269 - 273.
[Abstract] [PDF]


Home page
Arch NeurolHome page
K. Urakami, Y. Adachi, and K. Takahashi
A Community-Based Study of Parental Age at the Birth of Patients With Dementia of the Alzheimer Type
Arch Neurol, January 1, 1989; 46(1): 38 - 39.
[Abstract] [PDF]


Home page
Arch Gen PsychiatryHome page
G. S. Zubenko, F. J. Huff, J. Beyer, J. Auerbach, and I. Teply
Familial Risk of Dementia Associated With a Biologic Subtype of Alzheimer's Disease
Arch Gen Psychiatry, October 1, 1988; 45(10): 889 - 893.
[Abstract] [PDF]


Home page
ANN INTERN MEDHome page
H. V. Vinters, B. L. Miller, and W. M. Pardridge
Brain Amyloid and Alzheimer Disease
Ann Intern Med, July 1, 1988; 109(1): 41 - 54.
[Abstract] [PDF]


Home page
Arch NeurolHome page
K. Urakami, Y. Adachi, and K. Takahashi
A Community-Based Study of Parental Age in Alzheimer-Type Dementia in Western Japan
Arch Neurol, April 1, 1988; 45(4): 375 - 375.
[Abstract] [PDF]


Home page
Arch Gen PsychiatryHome page
R. C. Mohs, J. C. S. Breitner, J. M. Silverman, and K. L. Davis
Alzheimer's Disease: Morbid Risk Among First-Degree Relatives Approximates 50% by 90 Years of Age
Arch Gen Psychiatry, May 1, 1987; 44(5): 405 - 408.
[Abstract] [PDF]


Home page
JAMAHome page
P. Sullivan, D. Petitti, and J. Barbaccia
Head Trauma and Age of Onset of Dementia of the Alzheimer Type
JAMA, May 1, 1987; 257(17): 2289 - 2290.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1986 by AAN Enterprises, Inc.